Volitionrx Ltd
USD1.36
-0.06 (-4.23%)
CEO
Cameron Reynolds
IPO Date
2012-03-02
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.41
Prev. Close
$1.42
Day Low
$1.34
Day High
$1.41
52W Low
$1.17
52W High
$16.40
Market Cap
$0.01B
Volume
0.01M
| 3,948 |
| $0.19 |
| 19 Mar 2026 | Micallef Jacob Vincent | Chief Scientific Officer | F-InKind | Disposed | 5,310 | $0.19 |
| 19 Mar 2026 | Plummer Nicholas | GC - Volition Diagnostics | F-InKind | Disposed | 7,003 | $0.19 |
| 3 Mar 2026 | Rootsaert Rodney Gerard | Secretary | F-InKind | Disposed | 3,321 | $0.21 |
| 3 Mar 2026 | Forterre Gael | Chief Commercial Officer | F-InKind | Disposed | 2,283 | $0.21 |
| 3 Mar 2026 | Plummer Nicholas | GC - Volition Diagnostics | F-InKind | Disposed | 5,867 | $0.21 |
| 27 Feb 2026 | Forterre Gael | Chief Commercial Officer | A-Award | Acquired | 149,000 | $0.00 |
| 27 Feb 2026 | Rubin Ethel | director | A-Award | Acquired | 178,000 | $0.00 |
| 27 Feb 2026 | Reynolds Cameron John | director, officer: President and CEO | A-Award | Acquired | 486,000 | $0.00 |